INVO Fertility, Inc.
INVO Fertility Reports Third Quarter 2026 Results Highlighting 28% Clinic Revenue Growth and Continued Positive Clinic-Level Adjusted EBITDA
Record quarterly clinic revenues supported by both organic growth and acquisitions
Company newsroom
NASDAQ:IVF
1 releases
Record quarterly clinic revenues supported by both organic growth and acquisitions